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Abstract 
Objectives: To explore the experience of CRS and its management from the 
perspective of patients with CRS. To our knowledge this is the first qualitative study 
exploring sinus disease. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Design: Semi-structured qualitative interviews 
Setting:ENT outpatient clinic 
Participants: 21 adult patients with CRS: 11 male, 10 female. Patients suffered from 
a range of types of CRS (including polyps and fungal disease) and differing durations 
of symptoms (1.5- 47 years). Participants were purposively selected. Thematic 
analysis was used. 
Outcome measures: Patient experience of CRS and its management. 
Results: Patients had concerns regarding management of their symptoms by both 
healthcare professionals and themselves, including delays to referral and repeated 
medications. They reported reduced quality of life and high financial and 
psychosocial costs associated with living with CRS. 
Conclusions: Despite guidelines for CRS treatment, outcomes remain variable 
leading to dissatisfaction with treatment. Adherence to existing guidelines may result 
in fewer repeated consultations in primary care and earlier referrals to secondary 
care. 
 
Key words: General practice, nasal obstruction, quality of health care, rhinitis, 
paranasal sinus disease 
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Abbreviations: 
CRS – Chronic rhinosinusitis, CRSwNP – Chronic rhinosinusitis with nasal polyps, 
CRSsNP – Chronic rhinosinusitis without (sans) nasal polyps, AFRS – Allergic fungal 
rhinosinusitis 
 
Background 
Rhinosinusitis is one of the most common health problems in the Western world 1 
with a recent European study estimating the prevalence of chronic rhinosinusitis 
(CRS) at 11% 2 . It isdefined as inflammation of the nose and paranasal sinuses 
characterised by symptoms of nasal blockage and/or nasal discharge and may 
include facial pain and loss of smell according to the diagnostic criteria of the 
European Position Paper on Rhinosinusitis and Nasal Polyps3 . Chronic disease is 
distinguished from acute by the persistence of symptoms for at least 12 weeks4. 
 
Morbidity is considerable, reaching into physical, social and emotional indices of 
health. In addition to nasal symptoms, CRS patients consistently report lower health-
related quality of life with adverse effects on olfaction, sleep quality, sexual function, 
work productivity and mental health 5; these have been reported to be worse than in 
patients with other chronic illnesses frequently seen in primary care such as:COPD, 
back pain and heart failure 6. The direct and indirect costs are consequently large, 
although as yet not quantified in a British setting. 
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The majority of CRS is diagnosed and managed in primary care 7 and is usually 
made on the basis of nasal symptoms alone. In secondary and tertiary care, anterior 
rhinoscopy, nasal endoscopy and CT scanning can be employed to confirm the 
diagnosis of CRS. Evidence-based treatment options for chronic rhinosinusitis 
include nasal irrigation with saline, intranasal or oral steroids, and oral antibiotics 8, 9.  
 
The use of guideline-based treatment has been shown to improve quality of life and 
reduce symptoms in comparison to free-choice treatment 10 and guidelines for the 
management of CRS have been recently updated 3, 4, 11-13 including guidance 
documents specifically for primary care 11. Despite suchguidelines, uptake and 
utilisation in primary and secondary care in the UK is not consistent 14.Treatment 
therefore remains variable with neither primary care physicians or patients satisfied 
with management of sinus disease 1516. 
 
Optimum management of patients with chronic conditions is usually achieved 
through therapeutic partnerships with health professionals 17. ‘Management’ in the 
context of chronic disease includes a patient’s whole experience of an illness and 
treatment and is consequently often investigated through qualitative interviews 
allowing detailed exploration of relevant issues. It is seen as an increasingly 
important aspect of primary care. Yet in contrast to a wealth of qualitative literature 
regarding chronic conditions such as asthma 18 and diabetes, this study, to the best 
of our knowledge, is the first study to explore the experience of CRS and its 
management from patients’ perspectives. Some previous work has looked at the 
impact of allergic rhinitis; one US study found approximately 30% of physicians 
underestimated the severity of allergic rhinitis and its effect on work and social 
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activities4. The EPOS3 guidelines have also suggested that more work is needed to 
explore the impact of CRS. 
 
Methods 
Semi-structured interviews with 21 purposively selected patients attending a 
specialist rhinology clinic were undertaken. Patients were selected to include a range 
of duration and management (surgical and medical) of CRS and different subtypes of 
disease. They were identified from the senior author’s tertiary rhinology clinic to 
include both new and follow-up patients. Only one patient approached declined 
interview as he was unable to attend during the time period of the study, March to 
June 2012. Whilst only patients who had been referred to secondary care were 
sampled for this study, all had had to pass through primary care to be referred. 
 
This study was reviewed and approved by Oxford ‘C’ Ethics Committee. Participants 
were refunded for travel and parking and given a £20 shopping voucher for 
participation. 
 
An interview template was produced; this was designed by the interviewer (SE) a 
qualitative researcher (CN) and the senior author to ensure it included the broad 
range of concerns raised in clinic by patients. Potential concerns wereidentified by 
the senior author and from quality of life studies including CRS patients as well as 
similar research including patients with asthma, but also allowing scope for patients 
to raise their own concerns. The template was piloted on a patient with CRS who 
agreed to participate and give feedback.  In line with qualitative research 
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methodology, novel issues which came to light during early interviews were included 
in the template for subsequent interviews19.  
 
The patients selected and the interview design were chosen to maximise the 
likelihood of including the greatestrange of issues of patients, known as ‘maximum 
variation sampling’, and to achieve saturation of themes during subsequent 
analysis20. Patients were selected to include adult males and females across a 
spread of ages with different types of CRS. The exact numbers of interviews 
required varies greatly in qualitative research; an acceptable number of patients 
were included for a study of this type to saturate themes and enable meaningful 
analysis. The number of participants was agreed prior to the start of recruitment; this 
is in excess of the twelve which are generally thought to be required to achieve 
saturation of themes,20 but it was intended to include a heterogeneous mix of 
patients with CRS so a larger number was selected according to qualitative research 
principles20-22 which allow flexibility to suit the type of participants, interviews and 
objectives of the study. 
 
Once the study had been explained, patients could choose when to participate in the 
qualitative interview. Interviews were carried out in a separate room adjacent to the 
rhinology clinic by a clinician trained and experienced in qualitative research 
methods and lasted between 50 and 90 minutes. Participants could decide to have 
the interview on the day of their clinic appointment or come back at another time 
more convenient to them. This clinician undertaking the interviews was not involved 
directly in participants’ clinical care. Interviews were recorded and transcribed.   
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Thematic analysis of the transcripts was undertaken; interviews were transcribed 
precisely as spoken and checked against recordings for accuracy. Both frequently 
occurring and important themes were highlighted, considered and coded 16, 23.To our 
knowledge, there is no similar qualitative study of patients with any form of sinus 
disease. The aims of this analysis were therefore exploratory, to generate novel 
themes. It was carried out using Nvivo 10, a software package for organising the 
analysis of qualitative research. All transcripts were analysed by one researcher with 
two other researchers analysing selected transcripts to ensure consistency and 
reduce researcher bias.  
 
The scope of the overall themes identified was too great in breadth to be considered 
with sufficient detail in one paper (see table 1). This analysis reports the factors 
perceived as relevant to patient care both for management in primary care, and 
referral to secondary care. Many participants had considerable frustrations with an 
aspect of CRS management so the themes contributing most to this feeling have 
been included here. Themes such as perceived trigger factors were considered as a 
separate issue by most participants and so will be considered in a following paper. 
The interaction between CRS symptoms and other respiratory problems was an 
important issue, and whilst relevant to theoverarching ‘management’ theme, it was 
an issue for specific participants only, and is related to the aetiology of their 
symptoms; it will therefore also be considered separately. 
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Results 
Participants  
The age range of participants was 24-75 years with 10 females and 11 males. 
Patients suffered from different types of CRS (established from clinical information 
and according to EPOS 2012 criteria3): 
CRS without nasal polyps (CRSsNP) 6, CRS with nasal polyps (CRSwNPs) 10, 
allergic fungal rhinosinusitis (AFRS) 5. Patient estimated duration of symptoms was 
1.5 to 47 years with a mean of 19.7 and median 14.5 years.  
 
Table 1: Showing themes and subthemes identified from analysis of all interviews. 
Themes in bold are considered in this analysis. 
 
Those themes including topics relevant to access to care (bold) are discussed in 
more detail as follows. 
 
Symptom and duration of symptoms 
Patients described a wide range of physical symptoms. 
 ‘I was just producing a lot of mucus….. I’m constantly blowing my nose and I’ve lost 
my sense of smell.’ Patient 9 (Male, 55, AFRS) 
‘I get horrible yellow catarrh, …just you know all the time.’ Patient 2 (Female, 62, 
CRSwNP) 
However, the onset of symptoms varied greatly. Many patients felt their symptoms 
had had an insidious onset, others said they could name a triggering incident or time 
period where symptoms had begun.  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
‘I found that I was getting cold like symptoms every winter and year by year they 
seemed to be lasting longer’.  Patient 9 (Male, 55, AFRS) 
 
Treatment seeking and referral 
Treatment–seeking behaviour varied greatly. Some patients had treated themselves 
for many years prior to seeking further treatment. Others visited their GP/ several 
GPs and tried a range of topical and systemic treatments. Some felt this was 
acceptable; others wanted a prompt referral tosecondary care when treatment or 
investigation was unsatisfactory.  
‘My one thing would be I’ve had them [symptoms] now for quite a few years… if it 
turns out that it is something [sinister] I’ll be pretty miffed that  I wasn’t referred that 
long ago.’ Patient 11 (Male, 34, CRSsNP) 
Referral (or lack of referral) to secondary care was prompted both by GP suggestion 
and patient request. Reasons for onward referral included failed treatment and 
patient concern.  
‘He never referred me because I didn’t consider it a really big problem.’ Patient 
2(Female, 62, CRSwNP) 
 
Problems with treatment 
Neither treatment in primary nor secondary care was entirely satisfactory to some 
patients.Sometimes this was due to unsatisfactory consultations; others felt their 
symptoms were not taken seriously. 
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 ‘I mean it’s just annoying that you’ve got to stop work go and queue up at the GP’s 
sit there to be told well they can’t find anything.’ Patient 4 (Male, 53, CRSsNP) 
‘No one (primary care) ever looked up my nose really to see if there was anything 
there.’  Patient 5 (Male, 53, CRSwNP) 
It was not only in primary care where patients were met with frustrations. Some of 
the patients found repeated consultations in an ENT clinic did not improve their 
problems. 
‘I did go on [the internet] and it did say you know if you have a good consultant they 
will do the allergy test, the camera and a CT scan. I never got that far so I was a little 
bit upset about that.’ Patient 13 (Female, 58, CRSsNP) 
Most described several courses of different, often ineffective treatments, which were 
not always reviewed. 
‘Everything I tried was so random.’ Patient 17 (Female, 47, AFRS) 
‘I was put onto Betnesol nasal drops, remained on them until last year [without 
significant benefit. Patient had been on this treatment for 40 years]. Patient 8 
(Female, 73, CRSwNP) 
Others did experience improvement but found it was not sustained. 
‘The combination of antibiotics and steroids was very, very effective, very quickly, but 
it didn’t last; it would just be for the time that I was taking the tablets.’   Patient 17 
(Female, 47, AFRS) 
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As expected surgery often bought about more immediate benefits, although some 
patients were disappointed at the short lived benefits of treatment. 
‘I’ve had polyps removed twice but you know it brings about marginal improvement 
for a while but it doesn’t change the condition noticeably’  Patient 9 (Male, 55, AFRS) 
Many wished that they had been able to access more effective treatment more 
quickly. 
‘Actually you realise after you’ve had something like this [comprehensive sinus 
surgery] done how different you feel and to know that I’ve spent years of my life not 
really 100% well is a bit annoying.’ Patient 17 (Female, 47, AFRS) 
 
Interaction with other illnesses 
Reported elsewhere24 
Another issue reported was interaction with other illnesses, this may also mask 
diagnosis.  
‘My GP kept saying oh well you’ve got a touch of bronchitis and all kinds of things 
like that … I was referred to the chest clinic… then the consultant at the chest clinic 
said well whilst your nose is so congested your chest will never be free so I suggest 
you go and see an ENT consultant.’ Patient 8 (Female, 73, CRSwNP) 
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Impact on daily living 
Impact on daily life ranged hugely. CRS is a disease very rarely associated with life 
threatening problems but despite this, symptoms were troublesome enough to worry 
many patients that they had a sinister underlying pathology. 
‘You start worrying about various things like you know with obviously like cancer … 
that does play on my mind um quite a bit at times and obviously that’s a lot of the 
reason why I did go back to the GP. ’ Patient 11 (Male, 34, CRSsNP) 
Some participants did not feel their symptoms were very problematic whilst others 
described a bleak outlook influencing every sphere of their life.  
‘You get to the point where…you’re quite tolerant…you’ll put up (with) an awful lot as 
a human being, you’ll just cope, but then you start to think what if I didn’t have to, 
how would I feel, what would my life be like?’ Patient 17 (Female, 47, AFRS) 
'‘I think I was about 14 I tried to commit suicide because it got so bad it really you 
know it seemed like no one was helping me [although] I was going to my doctors 
explaining everything to him.’ Patient 7 (Male, 24, CRSsNP) 
Impact on work and social functioning was also impaired. 
‘If I’m getting majorly congested my over the telephone it is awkward people ask me 
to repeat myself.’ Patient 1 (Female, 56, CRSwNP) 
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Financial burden 
The financial impact was discussed. This related to seeking alternative treatments 
when conventional NHS care proved unsatisfactory. 
‘He’s a chiropractor... I was seeing him every six weeks and his charges were pretty 
high... 4  to 5 thousand pounds... but it’s something I’m passionate about I want as 
does everyone really want to find the root cause.’ Patient 20 (Male, 35, AFRS) 
As well as the cost of over the counter medications and prescriptions. 
‘Your GP should give you the whole twelve weeks in one prescription… you could 
have a prescription for a period of time and you’ll get like seven days’ worth and 
you’re back ‘I’ll give you another two weeks’ and then there’s two things, it adds up 
and that’s extortionate.’ Patient 11 (Male, 34, CRSsNP) 
 
Discussion 
Key findings 
CRS is extremely common and associated with significant morbidity but several 
participants felt symptoms were not necessarily taken seriously. Although treatments 
are available, these interviews highlight areas in which outcomes are clearly not yet 
satisfactory and with costs to both the individual and the economy. Diagnosis and 
treatment of CRS is dependent on a patient presenting, usually to their GP.  This 
may be preceded by years of occasional medication use and recurring symptoms; 
patients with CRS frequently self-medicate with both over-the-counter (OTC) 
remedies and complementary medicines, evident in both the interviews and in larger 
quantitative studies 25-27. This may underlie why most patients present in middle age; 
they have an insidious onset with gradually worsening symptoms. Some participants 
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were frustrated by repeated ineffective medications and a lack of systematic 
management, others were not sure how to use topical nasal products. Many 
participants alluded to the fact that there is often no one ‘cure’; better explanation by 
clinicians as to the nature of CRS may make ongoing medical treatment more 
understandable and acceptable. The degree of morbidity experienced vary widely 
from feeling congested to feeling suicidal. Patients had often shouldered significant 
financial burden in managing their CRS, not only through missing work due to poorly 
controlled symptoms but also when trying alternative therapies (with little evidence 
base) or looking for private health advise when they felt their NHS care had not been 
adequate. 
 
Strengths and limitations 
Involvement of patients in their own healthcare is increasingly recognised as 
important; these interviews are unique in allowing patients to raise their own 
concerns regarding management of CRS in a research setting. The themes are likely 
to resonate strongly with many clinicians’ clinical experiences. The wide range of 
participants ensures that themes associated with experience of CRS and 
management are as broad as possible althoughresults are not necessarily 
generalizable to a wider population. Participants were asked whether they would like 
to participate in the study following their consultation about their CRS; they may have 
felt obliged to participate, the risk of this was minimised as the person conducting the 
studies was not directly involved in the particpants’ care. 
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Comparison with other studies 
Few studies have directly addressed concerns of patients with CRS; this study 
allowed patients to discuss any issues surrounding CRS and its management which 
they felt are important. Our study reflects current literature in the great variation of 
experience of diagnostic tests and treatment in both primary and secondary care, 
with geographic variation as well variation between clinicians in the same centre 7, 10, 
28
. 
 
The existing literature paints a discordant picture between management of CRS 
recommended by specialists and reality. Few studies have directly addressed this 
issue, but the causes appear to be multilevel: patient concerns and expectations, 
variations in clinical practice, physician and patient education and health 
infrastructure may all feed into patterns of behaviour that contribute to sub-optimal 
outcomes with current management of this disease.A cross-sectional European 
survey of 2966 patients suggested that patients with allergic rhinitis tended to either 
self-medicate or present to the GP in order to request a specific treatment, rather 
than to have a two-way discussion about appropriate management 29 presenting the 
first of several obstacles to successful treatment. One clinical series in California 
found use of complementary and alternative medicine in as many as 43% of patients 
with a diagnosis of CRS, including dietary modifications, herbal therapy, 
acupuncture, homeopathy and chiropractice25. Whilst such strategies may prove 
effective for some, a lack of good quality advice or guidance from healthcare 
professionals  may mean patients suffer unnecessarily or turn to alternative medical 
therapies with little or no foundations in evidence 12, 30.   
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Other potential problems include short consultation times, lack of post-graduate 
training in ENT and/or allergy, lack of access to or lack of expertise in diagnostic 
tests; and uncertainty over when to refer to secondary or tertiary care31. One study of 
188 GPs with an interest in allergy and respiratory  disorders found that only 0.6% 
instigated appropriate management of treatment for allergic rhinitis 18. Additionally, 
there may be a discrepancy between physician and patient attitudes towards the 
severity of disease and treatment options4. For example, intranasal corticosteroids 
(INCs) have become established as first-line agents in the management of CRS. 
Whilst concerns over the side effects of oral steroids initially limited their widespread 
use, a multitude of randomised controlled trials have demonstrated the safety and 
efficacy of intranasal steroids. Both GPs and ENT surgeons frequently prescribe 
INCs but recent studies suggest significant concerns still exist amongst patients 
regarding INCs and damage to the nose, systemic side effects and addiction32. 
Lifestyle factors are poorly understood; they will be further investigated by this study 
group as part of a large multi-centre questionnaire study, the Chronic Rhinosinusitis 
Epidemiology Study (CRES). 
 
Many patients interviewed were frustrated with short courses of antibiotic or other 
treatment which had nil, or no sustained effect. GP prescribing of antibiotics was 
found to reach 74% in ‘sinus’ type complaints in one Dutch study 31   with higher 
rates of prescribing associated with lower GP knowledge of respiratory tract 
infections, lower perceived time available for consultation and with longer duration of 
the GP’s practice. A similar picture is likely to be found amongst GPs in the UK, 
despite neither BSACI guidelines 13 nor EPOS guidelines recommending antibiotics 
use by GPs for CRS 11.  Variation in surgical management was similarly great; 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
analysis of Hospital Episode Statistic (HES) data to encapsulate the picture at 
Primary Care Trust (PCT) level in the NHS, shows greater than five-fold variation in 
maximum and minimum surgical intervention rates, after standardisation by age and 
gender, ranging between 2.5 sinonasal procedures per 100,000 population per 
annum in London to 13.5 in Devon and Cornwall 33. 
 
Implications for research and/or practice 
Adherence to the EPOS guidelines would streamline management; commissioning 
guidelines from ENT-UK show clear treatment and referral pathways from primary 
care34. Correct treatment can only follow a correct diagnosis; it is known that nasal 
endoscopy improves the accuracy of a diagnosis of sinusitis, but it is acknowledged 
that widespread use in primary care would not be feasible8. Thus it is more important 
that referral to secondary care is undertaken if there is no symptomatic response to 3 
months of topical treatment; this did not always occur for our participants due to both 
patient and clinician preferences. One participant mentioned that no one had looked 
in his nose prior to referral to secondary care; basic anterior rhinoscopy may be 
feasible and helpful in primary care settings. 
 
The likely duration of treatment should be discussed and include the possibility of the 
need for treatment to be lifelong, to help manage both expectations of the outcome 
of treatment and to aid management of the financial burden of medication.Time 
should be taken to explain how to use topical treatments to maximise their effect. 
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The formal synthesis of patients’ views highlights the need for research to better 
understand CRS and its management. Given the popularity of self–medication, this 
this may include alteration of service provision away from the clinician towards 
community pharmacy and non-clinicians. It will become increasingly important to 
quantify the financial burden of CRS both to individuals and to the NHS. Efficient 
care is needed and is likely to be improved by better use of current guidelines 3,35. 
Research is also needed to clarify our understanding of the epidemiology of CRS to 
enable development of more effective medical and surgical treatments; these data 
support such research proposals. 
 
Our study underlines the wide range of morbidity associated with CRS as well as 
potential weaknesses in management pathways. Reflecting on such concerns and 
considering them when managing patients with CRS will improve care for such 
individuals. 
 
Funding: This research received no specific grant from any funding agency in the 
public, commercial or not-for-profit sectors. Consumable costs were covered by the 
Anthony Long Trust. 
Words: 2512excluding patient quotations (3581 including) 
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Table 1 - Themes raised 
Themes raised  
Perceived triggering factors 
      Environmental 
      Dietary 
Family history 
Symptoms 
     Duration of symptoms 
Treatment seeking 
      Self-treatment 
      Delayed referral 
Problems with treatment 
      Repeated or unsuccessful medical         
      treatments, often costly 
      Continuity of care 
      Lifelong treatment 
      Side effects and limitations of surgery  
Impact on daily living
     Sleep 
Anosmia  
     Work and social functions 
     Relationships 
Interaction with other illnesses 
       Asthma 
       Need for integrated management with 
other specialties (allergy, respiratory) 
Financial burden 
      Cost of treatment 
      Missed work 
 
 
 
 
